Y-mAbs Therapeutics, Inc. - 984241109

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2025 · Q1 2025
Value (USD)
Total reported value ($000)
$117.5M
QoQ value delta ($000)
+$29.3M (+33.23%)
Implied price effect (QoQ)
+1.81%
Shares
Total shares
26,055,752
QoQ shares delta
+6,144,629 (+30.86%)
Total shares held by funds (by quarter)

Top holders (Q2 2025)

Top 25 only Full list
Early Q3 2025 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Paradigm Biocapital Advisors LP 19,105 4,236,346 0.82%
ACORN CAPITAL ADVISORS, LLC 15,419 3,418,995 10.08%
BlackRock, Inc. 12,393 2,748,077 0.0%
Caligan Partners LP 10,565 2,342,609 2.03%
Sofinnova Investments, Inc. 9,896 2,194,278 0.61%
VANGUARD GROUP INC 8,764 1,943,285 0.0%
GEODE CAPITAL MANAGEMENT, LLC 3,827 848,461 0.0%
STATE STREET CORP 3,518 780,145 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 3,128 693,693 0.06%
D. E. Shaw & Co., Inc. 2,331 516,857 0.0%
DIMENSIONAL FUND ADVISORS LP 1,859 412,246 0.0%
Nantahala Capital Management, LLC 1,586 351,878 0.06%
Soleus Capital Management, L.P. 1,578 349,982 0.1%
NORTHERN TRUST CORP 1,389 308,130 0.0%
MORGAN STANLEY 1,319 292,567 0.0%
Stonepine Capital Management, LLC 1,286 285,300 1.26%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,254 278,179 0.0%
BANK OF AMERICA CORP /DE/ 1,236 274,164 0.0%
AQR CAPITAL MANAGEMENT LLC 1,137 252,142 0.0%
CITADEL ADVISORS LLC 1,044 231,642 0.0%
UBS Group AG 1,033 229,072 0.0%
GOLDMAN SACHS GROUP INC 959 212,751 0.0%
GSA CAPITAL PARTNERS LLP 839 186,062 0.06%
RENAISSANCE TECHNOLOGIES LLC 740 164,100 0.0%
JPMORGAN CHASE & CO 739 164,055 0.0%